Eli Lilly's GLP-1 drugs have seen strong demand, which has investors excited about the future. The company knows that its GLP-1 success won't last forever and is exploring additional paths. Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results